John C. Arthur
Corporate Officer/Principal bij HERON THERAPEUTICS, INC.
Profiel
John C.
Arthur is currently the Vice President-Manufacturing & Supply at Heron Therapeutics, Inc. He was previously the Senior Director-Manufacturing at Auspex Pharmaceuticals, Inc. and the Vice President-Manufacturing & CMC at Mast Therapeutics, Inc. Dr. Arthur holds a doctorate degree from the University of South Carolina and an undergraduate degree from Western Washington University.
Actieve functies van John C. Arthur
Bedrijven | Functie | Begin |
---|---|---|
HERON THERAPEUTICS, INC. | Corporate Officer/Principal | 01-01-2017 |
Eerdere bekende functies van John C. Arthur
Bedrijven | Functie | Einde |
---|---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01-01-2016 |
AUSPEX PHARMACEUTICALS INC | Corporate Officer/Principal | 01-01-2013 |
Opleiding van John C. Arthur
University of South Carolina | Doctorate Degree |
Western Washington University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
HERON THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | Health Technology |
Auspex Pharmaceuticals, Inc.
Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA. | Health Technology |